Professional

First IPIG International Workshop Recent Advances in PNH and Aplastic Anemia

2nd Quarter 2021 - Dates to be determined

Harrogate Convention Centre

PRELIMINARY AGENDA

Wednesday, 20 May (beginning 13:00)

(Open to independent academic and clinical members only)

  1. PNH guidelines (diagnosis and treatment assessment)
  2. Patient registry
  3. IPIG strategic priorities, 2020-2025

 

Thursday, 21 May (beginning 08:30)

(Open to all)

  1. Pathophysiology of PNH
    1. Current understanding of the pathophysiology of PNH
    2. Molecular and biologic aspects of the GPI-defect in PNH
    3. Mechanism of thrombosis
  2. Diagnosis and Investigation
    1. Diagnostic testing for PNH
    2. Investigation of PNH
    3. Definition of breakthrough
  3. Current Thoughts on the Complement System
    1. Recent developments in the terminal complement inhibition in PNH
    2. Proximal complement inhibition in PNH
  4. Discussion / Abstracts
  5. Recent data on complement inhibition in PNH (corporate presentations)
  6. Posters
  7. Member reception

 

Friday, 22 May (beginning 08:30; ending 13:00)

(Open to all)

  1. Aplastic Anaemia
    1. Recent insights into the pathophysiology of AA
    2. Current non-transplant management of AA
    3. Transplant/cellular therapies in AA and PNH
  2. Definitions, guidelines, PNH across the globe
  3. Abstracts / Discussion

Faculty

  • Bing Han, MD
    Department of Haematology
    Peking Union Medical College Hospital
    Beijing, China
  • Peter Hillmen, MB, ChB,PhD
    St. James’s Institute of Oncology
    Leeds Teaching Hospitals
    NHS Trust
    Leeds, United Kingdom
  • Taroh Kinoshita, PhD
    Department of Immunoregulation
    Research Institute for Microbial Diseases
    Osaka University
    Osaka, Japan
  • Alexander Kulagin, MD, PhD
    Pavlov First St. Petersburg State Medical University
    St. Petersburg, Russia
  • Austin Kulasekararaj, MBBS, MD
    King’s College Hospital
    NHS Foundation Trust
    London, United Kingdom
  • John D. Lambris, PhD
    University of Pennsylvania Perelman School of Medicine
    Philadelphia, Pennsylvania, USA
  • Saskia Langemeijer, MD
    Radboud University Medical Center
    Nijmegen, Netherlands
  • Regis Peffault de Latour, MD, PhD
    Research Institute for Microbial Diseases
    Hôpital Saint-Louis
    Paris, France
  • Jong Wook Lee, MD
    The Catholic University of Korea
    Seoul St. Mary’s Hospital
    Seoul, Korea
  • Lucio Luzzatto, MD
    Muhimbili University of Health and Applied Sciences
    Dar es Salaam, Tanzania
  • Judith Marsh, BSc, MB, ChB
    King’s College Hospital
    NHS Foundation Trust
    London, United Kingdom
  • Petra Muus, MD, PhD
    Department of Haematology
    King’s College Hospital
    London, United Kingdom
  • Shinji Nakao, MD, PhD
    Cellular Transplantation Biology
    Kanazawa University Graduate School of Medical Science
    Kanazawa, Ishikawa, Japan
  • Junichi Nishimura, MD, PhD
    Osaka University Graduate School of Medicine
    Osaka, Japan
  • Charles J. Parker, MD
    Division of Hematology and Bone Marrow Transplantation
    University of Utah School of Medicine
    Salt Lake City, Utah, USA
  • Stephen John Richards, PhD
    Leeds Teaching Hospitals
    NHS Trust
    Leeds, United Kingdom
  • Antonio M. Risitano, MD, PhD
    Federico II University
    Naples, Italy
  • Gérard Socié, MD, PhD
    Hôpital Saint-Louis
    Paris, France
  • Jeff Szer, BMedSc MB BS
    Peter MacCallum Cancer Centre
    The Royal Melbourne Hospital
    Victoria, Australia
  • Ronald P. Taylor, PhD
    Department of Biochemistry
    University of Virginia
    Charlottesville, Virginia, USA
  • Russell E. Ware, MD, PhD
    Cincinnati Children’s Hospital
    Cincinnati, Ohio, USA
  • Neal S. Young, MD
    National Heart, Lung, and Blood Institute
    National Institutes of Health
    Washington, DC, USA
  • Rodrigo T. Calado, MD, PhD
    Department of Internal Medicine
    Ribeirão Preto School of Medicine University of São Paulo
    Ribeirão Preto, Brazil
  • Phillip Scheinberg, MD
    Hospital São José
    Beneficencia Portuguesa de São Paulo
    São Paulo, Brazil

 

The registration fee for this event is £50(GBP)

There are a number available for trainees and young investigators. More information will be available soon.

To register your interest in receiving updates about this workshop, please contact derry@collaborativeconferences.co.uk

For corporate sponsorship enquiries, please contact Heather Hollowell: info@pnhinterestgroup.org

More information in our Preliminary workshop brochure

Upcoming meetings of interest to IPIG members

25th EHA Anniversary Congress

· EHA25 Virtual Congress, June 11-14, 2020: Invited speakers, abstract presenters, satellites by pharmaceutical companies.

· EHA25 Virtual Thematic Days, June 15-21, 2020: Overview sessions and special Q&A panel discussions.

11 - 21 Jun 2020
EHA25 Virtual

Help us expand our Resources

If you have information or resources you’d like to submit for inclusion on our IPIG website, our board will be happy to consider your submission.

Find out how to submit a resource